Edition:
India

Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

103.97USD
20 Sep 2019
Change (% chg)

$0.57 (+0.55%)
Prev Close
$103.40
Open
$103.19
Day's High
$104.73
Day's Low
$100.60
Volume
2,177,740
Avg. Vol
550,124
52-wk High
$123.94
52-wk Low
$53.09

Select another date:

Mon, Jul 29 2019

Photo

Diagnostic company Exact Sciences to buy Genomic Health in $2.8 billion deal

Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about $2.8 billion in cash and stock, expanding the cancer diagnostic company's testing capabilities to breast and prostate cancers.

UPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal

July 29 Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about $2.8 billion in cash and stock, expanding the cancer diagnostic company's testing capabilities to breast and prostate cancers.

Deals of the day-Mergers and acquisitions

July 29 The following bids, mergers, acquisitions and disposals were reported by 1300 GMT on Monday:

Exact Sciences to buy Genomic Health for $2.8 billion

July 29 Cancer diagnostics company Exact Sciences Corp said on Monday it will buy healthcare company Genomic Health Inc for about $2.8 billion to bolster its cancer testing business.

Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

Cancer diagnostics company Exact Sciences Corp is in advanced negotiations to buy healthcare company Genomic Health Inc for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday.

Exact Sciences in advanced talks to buy Genomic Health for $2.8 bln- Bloomberg

July 27 Cancer diagnostics company Exact Sciences Corp is in advanced negotiations to buy healthcare company Genomic Health Inc for about $2.8 billion to strengthen its cancer testing, Bloomberg reported https://bloom.bg/2K516Ym on Saturday.

Select another date: